Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Creation and validation of the harmonized Arabic version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP).
Awad MA, Hallgarth L, Barayan GA, Shahait M, Abu-Hijlih R, Farkouh A, Azhar RA, Alghamdi MM, Bugis A, Yaiesh S, Aldousari S, Barham A, Saed M, Moussa A, Hassen W, Naud S, Plante MK, Grunert R. Awad MA, et al. Among authors: shahait m. Arab J Urol. 2021 Nov 28;20(2):88-93. doi: 10.1080/2090598X.2021.2002636. eCollection 2022. Arab J Urol. 2021. PMID: 35530568 Free PMC article.
When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level.
Falagario UG, Chakravarty D, Martini A, Shahait M, El-Fahmawi A, Jambor I, Lantz A, Grannas D, Ratnani P, Parekh S, Lundon D, Haines K, Cormio L, Carrieri G, Kyprianou N, Kattan MW, Klein EA, Wiklund P, Lee DI, Tewari A. Falagario UG, et al. Among authors: shahait m. World J Urol. 2023 Jan;41(1):85-92. doi: 10.1007/s00345-022-04240-8. Epub 2022 Dec 9. World J Urol. 2023. PMID: 36484816
Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation.
Geara FB, Bulbul M, Khauli RB, Andraos TY, Abboud M, Al Mousa A, Sarhan N, Salem A, Ghatasheh H, Alnsour A, Ayoub Z, Gheida IA, Charafeddine M, Shahait M, Shamseddine A, Gheida RA, Khader J. Geara FB, et al. Among authors: shahait m. Radiat Oncol. 2017 Sep 7;12(1):149. doi: 10.1186/s13014-017-0884-y. Radiat Oncol. 2017. PMID: 28882187 Free PMC article.
High rates of advanced prostate cancer in the Middle East: Analysis from a tertiary care center.
Daher M, Telvizian T, Dagher C, Abdul-Sater Z, Massih SA, Chediak AE, Charafeddine M, Shahait M, Alameddine R, Temraz S, Geara F, Youssef B, El Hajj A, Nasr R, Wazzan W, Bulbul M, Khauli R, Shamseddine A, Mukherji D. Daher M, et al. Among authors: shahait m. Urol Ann. 2021 Oct-Dec;13(4):418-423. doi: 10.4103/UA.UA_47_20. Epub 2021 Jun 23. Urol Ann. 2021. PMID: 34759656 Free PMC article.
Allocation of the "Already" Limited Medical Resources Amid the COVID-19 Pandemic, an Iterative Ethical Encounter Including Suggested Solutions From a Real Life Encounter.
Alhalaseh YN, Elshabrawy HA, Erashdi M, Shahait M, Abu-Humdan AM, Al-Hussaini M. Alhalaseh YN, et al. Among authors: shahait m. Front Med (Lausanne). 2021 Jan 14;7:616277. doi: 10.3389/fmed.2020.616277. eCollection 2020. Front Med (Lausanne). 2021. PMID: 33521023 Free PMC article. Review.
83 results